An AGEP case due to COVID-19 or favipiravir or enoxaparin

dc.contributor.authorDaye, Munise
dc.contributor.authorOltulu, Pembe
dc.date.accessioned2024-02-23T14:24:29Z
dc.date.available2024-02-23T14:24:29Z
dc.date.issued2022
dc.departmentNEÜen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.identifier.doi10.1111/jocd.14622
dc.identifier.endpage15en_US
dc.identifier.issn1473-2130
dc.identifier.issn1473-2165
dc.identifier.issue1en_US
dc.identifier.pmid34826196en_US
dc.identifier.scopus2-s2.0-85119961517en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage13en_US
dc.identifier.urihttps://doi.org/10.1111/jocd.14622
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13966
dc.identifier.volume21en_US
dc.identifier.wosWOS:000722684100001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofJournal Of Cosmetic Dermatologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAcute Generalized Exanthematous Pustulosis (Agep)en_US
dc.subjectCovid-19en_US
dc.subjectEnoxaparinen_US
dc.subjectFavipraviren_US
dc.titleAn AGEP case due to COVID-19 or favipiravir or enoxaparinen_US
dc.typeEditorial Materialen_US

Dosyalar